Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!
A traditional Chinese medicine composition for alleviating sequelae of pelvic inflammatory disease and its application
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and technology for pelvic inflammatory disease, applied in the field of traditional Chinese medicine composition for relieving sequelae of pelvic inflammatory disease, can solve problems such as unsatisfactory antibacterial effect, achieve accurate and stable curative effect, reduce recurrence rate, and reduce serum inflammatory cytokine content.
Inactive Publication Date: 2019-09-03
HUANGHUAI UNIV
View PDF4 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Long-term use of antibiotics for anti-infection is prone to drug resistance, and the antibacterial effect is not satisfactory. The key to the treatment of this disease is to actively seek effective means that can stabilize the curative effect and prevent recurrence
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0026] The preparation of embodiment 1 Chinese medicine composition of the present invention (one)
[0027] Violet 25 parts, dandelion 20 parts, Daxueteng 10 parts, Bupleurum 12 parts, Corydalis 8 parts, Xu Changqing 15 parts (below), Liu Jinu 6 parts, Toosendan 12 parts, Citrus aurantium 6 parts, 15 parts of dog ridge, 10 parts of diaphan, decocted in conventional method.
Embodiment 2
[0028] The preparation of embodiment 2 Chinese medicine composition of the present invention (two)
[0029] Viola 35 parts, dandelion 10 parts, Daxueteng 20 parts, Bupleurum 6 parts, Corydalis 12 parts, Xu Changqing 10 parts (below), Liu Jinu 12 parts, Toosendan 6 parts, Citrus aurantium 12 parts, 10 parts of dog ridge, 15 parts of diaphan, decocted in conventional method.
Embodiment 3
[0030] The preparation of embodiment 3 Chinese medicine composition of the present invention (three)
[0031] Viola 25 parts, dandelion 10 parts, Daxueteng 20 parts, Bupleurum 12 parts, Corydalis 8 parts, Xu Changqing 10 parts (below), Liu Jinu 12 parts, Toosendan 12 parts, Citrus aurantium 6 parts, 10 parts of dog ridge, 15 parts of diaphan, decocted in conventional method.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to traditional Chinese medicine composition for relieving sequelae of a pelvic inflammatory disease and an application of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from raw materials in parts by weight as follows: 25-35 parts of philippine violet herb, 10-20 parts of dandelion, 10-20 parts of sargentgloryvine stems, 6-12 parts of radix bupleuri, 8-12 parts of corydalis yanhusuo, 10-15 parts of paniculate swallowwort roots, 6-12 parts of diverse wormwood herb, 6-12 parts of szechwan Chinaberry fruits, 6-12 parts of fructus aurantii, 10-15 parts of east asian tree fern rhizomes and 10-15 parts of himalayan teasel roots. The traditional Chinese medicine composition can effectively relieve clinical symptoms and signs of a patient suffering from sequelae of the damp heat and blood stasis type pelvic inflammatory disease, the factor content of inflammatory cells in serums is reduced, the pelvic inflammatory disease is inhibited, the recurrence rate is reduced, and the traditional Chinese medicine composition has good analgesia and anti-inflammatory effects and has definite and stable curative effect; the traditional Chinese medicine composition contains fewer herbal medicines, is convenient to prepare, safe and reliable and doesn't have toxic or side effects.
Description
technical field [0001] The invention relates to a traditional Chinese medicine composition for alleviating sequelae of pelvic inflammatory disease and its application, in particular to a Chinese patent medicine prepared from Chinese herbal medicines. Background technique [0002] Sequelae of pelvic inflammatory disease (Sequelae of PID) is mostly caused by pathogenic microorganisms invading the female upper reproductive tract and its surrounding tissues through various channels, causing pelvic tissue infection and inflammatory response. Pelvic organs, connective tissue, and mucous membranes can all be affected by inflammation, resulting in abnormal local tissue metabolism. If the infection is not treated promptly and correctly, it can lead to local congestion, edema, tissue destruction, extensive adhesions, fibrosis, hyperplasia, and scar formation. This disease is a common reproductive system disease in gynecology. In recent years, it has been rising and becoming younger. I...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More